News & Resources
EPAD General Assembly Meeting
The EPAD project will host its annual General Assembly meeting in Geneva. The event will bring together EPAD delegates to discuss progress, latest developments and future plans. In attendance will be scientists, researchers, representatives from pharmaceutical companies, patient organisations, SMEs, EPAD study site members, other experts and research participants from across many different countries.
HD-RSC Annual Meeting
The Huntington’s Disease Regulatory Science Consortium was formed with the goal of improving the regulatory path for emerging therapies for Huntington’s disease. This global initiative will facilitate collaboration among biopharma/technology industry partners, academic institutions, government agencies, and patient-advocacy organizations.
View
SCA Global Conference
The 1st Spinocerebellar Ataxia (SCA) Global Conference proved an exciting time for the Ataxia community, with a goal to assemble a global consortium for clinical studies of the spinocerebellar ataxias, (SCAs).
IXICO sponsored the event and presented a poster: ''Development of a fully automated method for MRI volumetry in ataxia''
14th Annual AD/PD
International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders.
As the industry continues to debate approaches to the long term solution to finding treatments in Alzheimer's disease, particularly following recent announcements of further late phase failures, IXICO is continuing in its work to support clinical research in these Therapeutic Areas through collaboration, partnership and innovation in technology that supports the increasing requirement for better data science.
Wearable Technology Show 2019
The Wearable Technology Show 2019 covered the latest innovations in digital health technology and wearables for continuous monitoring of activity, sleep and vital signs.
View
CHDI Huntington’s Disease Therapeutics Conference
The 14th Huntington’s Disease Therapeutics Conference provided a forum to review the significant progress in HD clinical development, learn about exciting new findings, and build a collaborative path forward to overcome the remaining challenges to accelerating the development of therapeutics that will substantially benefit HD families.
View
World CNS Summit
Featuring pharma R&D leaders, innovators on the cutting edge of technology, and visionaries that are shaping the future of healthcare.
View
13th Human Amyloid Imaging Conference
HAI 2019 will emphasize lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions primarily spring from brief presentations by active investigators who will report on unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer’s-related disease.
View161-168 of 168 results